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Abstract
Background: Clavicle fractures account for around 4% of all fractures and up to 44% of fractures of the shoulder
girdle. Fractures of the middle third (or mid-shaft) account for approximately 80% of all clavicle fractures.
Management of this group of fractures is often challenging and the outcome can be unsatisfactory. In particular it
is not clear whether surgery produces better outcomes than non-surgical management. Currently there is much
variation in the use of surgery and a lack of good quality evidence to inform our decision.
Methods/Design: We aim to undertake a multicentre randomised controlled trial evaluating the effectiveness and
safety of conservative management versus open reduction and internal fixation for displaced mid-shaft clavicle
fractures in adults. Surgical treatment will be performed using the Acumed clavicle fixation system. Conservative
management will consist of immobilisation in a sling at the side in internal rotation for 6 weeks or until clinical or
radiological union. We aim to recruit 300 patients. These patients will be followed-up for at least 9 months. The
primary endpoint will be the rate of non-union at 3 months following treatment. Secondary endpoints will be limb
function measured using the Constant-Murley Score and the Disabilities of the Arm, Shoulder and Hand (DASH)
Score at 3 and 9 months post-operatively.
Discussion: This article presents the protocol for a multicentre randomised controlled trial. It gives extensive details
of, and the basis for, the chosen methods, and describes the key measures taken to avoid bias and to ensure validity.
Trial Registration: United Kingdom Clinical Research Network ID: 8665. The date of registration of the trial is
07/09/2006. The date the first patient was recruited is 18/12/2007.
Background
Rationale for the trial
Clavicle fractures account for around 4% of all fractures
[1] and up to 44% of fractures of the shoulder girdle
[2,3]. Fractures of the middle third (or mid-shaft) account
for approximately 80% of all clavicle fractures [2,3].
Management of mid-shaft clavicular fractures is often
challenging and the outcome can be unsatisfactory. In
particular it is not clear whether surgery produces better
outcomes than non-surgical management. Traditionally
mid-shaft clavicular fractures have been managed con-
servatively, even when substantially displaced [4].
Recent literature has highlighted the high non-union
rate in displaced mid-shaft clavicular fractures, with a
non-union rate up to 15% [5-7]. Furthermore, there is
some evidence that conservative management affects the
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treatment of non-unions produces inferior results [11,12].
Few comparative studies of surgical versus non-surgical
treatment for mid-shaft clavicle fractures are available, and
contradictory results have been obtained [13-15].
In a randomised controlled trial, though patients with
mid-shaft clavicle fractures had higher functional scores
at short-term follow-up after internal fixation, functional
scores were similar at 6 months and 1 year. In addition,
internal fixation with a modified Hagie pin was asso-
ciated with a higher complication rate [13].
In a multicentre, prospective clinical trial [16], 132
patients with a displaced mid-shaft fracture of the clavi-
cle were randomized to either operative treatment with
plate fixation (67 patients) or nonoperative treatment
with a sling (65 patients). Operative fixation of a dis-
placed fracture of the clavicular shaft resulted in
improved functional outcome and a lower rate of mal-
union and non-union compared with nonoperative
treatment at one year of follow-up. Hardware removal
remained the most common reason for repeat interven-
tion in the operative group.
A formal cost-effectiveness analysis based on the same
prospective, randomized, controlled trial [14] proposed
that the cost-effectiveness of open reduction and inter-
nal fixation (ORIF) after acute clavicle fracture
depended on the durability of functional advantage for
ORIF compared with nonoperative treatment. When
functional benefits persisted for more than 9 years,
ORIF had a favourable value compared with many
accepted health interventions.
Two 2009 Cochrane reviews [1,11] on the manage-
ment of middle third clavicle fractures concluded that
there is insufficient evidence from randomised con-
trolled trials to determine which methods of conserva-
tive [11] and surgical [1] treatment are the most
appropriate for middle third clavicle fractures.
A 2010 systematic review [17] concluded that there is
moderate evidence that operative treatment for mid-
shaft clavicle fractures results in a lower rate of fracture
non-union and improved patient-oriented outcome
compared to non-operative treatment. However, because
union rates are generally high and there are complica-
t i o n sw h i c ha r eu n i q u et os u r gical intervention, risks
have to be considered before a decision on treatment is
made. The most important risk factors for non-union
are major displacement and fracture comminution. Of
all surgical procedures the best evidence of efficacy is
presently available for plate fixation and elastic stable
intramedullary nailing [17].
Trial aim
The aim of this multicentre randomised controlled trial
(RCT) is to compare the safety and effectiveness of
conservative and operative management of mid-shaft
fractures of the clavicle in adults. The primary outcome
will be the non-union at 3 months from injury. Second-
ary outcomes will be clinical scoring systems assessing
pain, mobility, strength and function at 3 and 9 months
follow-up.
Our null hypothesis is no difference in the non-union
rate at 3 months from injury and in scoring systems at
3 and 9 months follow-up between the 2 groups.
Methods/Design
Study Design
This is a multicentre randomised controlled trial com-
paring safety and effectiveness of conservative manage-
ment versus ORIF of mid-shaft clavicle fractures.
Setting
Patients will be recruited from the following centres:
Royal Free Hospital NHS Trust, University College
Hospitals NHS Foundation Trust, St Thomas’ and Guy’s
Hospitals NHS Foundation Trust, St George’s Hospital
NHS Trust, Yeovil District Hospital NHS Foundation
Trust, North Bristol NHS Trust, University Hospitals
Coventry and Warwick NHS Foundation Trust, The Ips-
wich Hospital NHS Trust.
Endpoints
The primary endpoint will be the rate of non-union at 3
months following treatment. Non-union is defined as
lack of radiographic healing at 3 month follow up
[16,18].
Secondary endpoints will be limb function measured
using the Constant-Murley Score [19] and the Disabil-
ities of the Arm, Shoulder and Hand (DASH) Score [20]
measured at 3 and 9 months post-operatively.
Ethical Considerations
Ethical approval
Ethical Approval has been obtained from the UK
National Research Ethics Service, Charing Cross Hospi-
tal Ethics Committee (for multicentre trials) Reference
number 06/Q0411/prior to commencement of this
study. Local Ethics Committee approval for each unit
involved in the trial will also be obtained.
Consent Procedures
Informed consent will be obtained from the patient
prior to randomization.
Eligible patients will be provided with a patient infor-
mation sheet and have the opportunity for discussion
with a principal investigator at their first orthopaedic
attendance. Patients will have up to a 24-hour period in
which to seek further advice and reflect before inclusion.
Inclusion criteria
￿ Age 18-65 years
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￿ Robinson Classification 2B1 and 2B2 [21]
￿ Displaced mid-shaft fracture, butterfly fragment +/-
comminution on radiographs
￿ Medically fit to undergo surgery (ASA grade 1-3)
Exclusion criteria
￿ Patient refusal
￿ Medically unfit (ASA Grade 4/5)
￿ All other clavicle fractures
￿ Established non-union from previous fracture
￿ Previous fractures around the clavicle
￿ Previous operations to shoulder or clavicle
￿ Metabolic bone disease
￿ Clinically important neuro-muscular upper limb
disability.
Recruitment
Patients will be identified at attendance to the accident
and emergency department at each hospital. They will
be referred to fracture clinic, as this is the usual prac-
tice, and identified as eligible for the trial by the consul-
tant surgeon in charge of the clinic.
It is estimated that in each centre approximately 2
patients per month will meet the inclusion criteria. It is
also estimated that 80% of these patients will consent to
be involved in the trial. Loss to follow-up will be small
until 3 months, though for final follow-up and assess-
ment is estimated a further 10% may be lost to follow-
up.
Randomisation
Randomisation lists will be computer generated. Lists
will be stratified by centre and blocked to ensure similar
numbers of patients are allocated to the treatment
groups within each centre. Allocations will be concealed
in sequentially numbered opaque envelopes held at each
site. 1 envelope will be opened for each patient. Eligible
patients will be provided with a patient information
sheet and consented using a trial consent form prior to
randomisation.
Blinding
Because of the nature of the study it will not be possible
to blind the patients or clinicians involved.
Baseline data collection
Baseline data will be collected on all patients before
consent. These will include patient demographics, side
of injury, mechanism of injury, fracture classification
[21], ASA grade and whether the patient is a smoker.
These data will be used to assess the balance in charac-
teristics achieved by randomisation and also to compare
the eligible group who declined to participate with the
randomised group.
Operative Details
All procedures will be performed in an orthopaedic
theatre under antibiotic cover according to local micro-
biology protocols in each centre. General anaesthetic
will be used for all patients with or without supplemen-
tary interscalene blockade. All surgical procedures will
be performed by one of the orthopaedic consultants
named in the protocol or by their specialist registrar/
research fellow under consultant supervision. All the
patients enrolled in the study will be treated in a stan-
dardised way.
An infraclavicular incision will be used and a myo-peri-
osteal flap elevated from the fracture segments. Fixation
will be performed using the Acumed clavicle fixation sys-
tem (Hillsboro, Oregon), consisting of a pre-contoured
titanium plate with 2.7 mm or 3.5 mm screws. Image
intensification will be available for all cases and hard
copies will be obtained at the end of each procedure.
Following wound closure the affected arm will be placed
in an arm sling. Mobilisation and rehabilitation will be
identical to the non-operative group (see below).
Data from the procedure will be documented on the
operation note, including any peri-operative complica-
tions or deviations from the standard technique.
Non-operative Treatment
The arm on the fractured side will be immobilised in a
sling at the side in internal rotation for 6 weeks or until
clinical or radiological union. Pendulum and elbow exer-
cises will be allowed the first day presenting in fracture
clinic. Patients will be allowed to remove the sling for
short periods to wash, dress, write, eat and use a key-
board as soon as comfort allows. Short-lever active and
active-assisted exercises below shoulder height are
allowed as tolerated. Active mobilisation above the hori-
zontal and cross-arm adduction will be commenced
after 6 weeks.
Post operative care
The same rehabilitation protocol will be used in patients
undergoing surgical management, starting on the first
day post-operatively.
Time-points
All patients will be followed up at 2 weeks, 6 weeks,
3 months and between 9 and 12 months from
randomisation.
Patients will be given follow up dates at each appoint-
ment and a supplementary reminder letter will be sent
to all patients before their 9 month appointment.
Assessment
For all subjects, radiographs will be performed at the
2w e e k ,6w e e ka n d3m o n t hf o l l o w - u p .T h e2w e e k
appointment will involve a clinical assessment to
exclude early complications related to the fracture or
surgery, and a routine radiograph to evaluate the frac-
ture position. The 6 week appointment will involve a
clinical assessment of fracture healing and a routine
radiograph to assess union. Radiological union will
be assessed by the principal investigator at each site. If
the fracture is radiographically united at 6 weeks no
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ment. In cases where there is doubt as to the degree of
union at 3 months the radiographs will be reviewed by a
principal investigator from another site. Clinical data of
union including fracture mobility, tenderness and pain
will also be obtained at each follow-up. The x-rays of
the first 40 subjects’ will be reviewed by an independent,
blinded radiologist, once the principal investigator has
j u d g e dt h ef r a c t u r et oh a v eu n i t e do rb eu n - u n i t e d .I f
there will be a discrepancy of opinion greater than 2%
(1 patient), this process will be continued for all trial
patients. For those radiographs where there is a discre-
pancy of opinion, the Chief Investigator will review the
case and a majority consensus opinion will be gained
from 3 Principal Investigators.
The Constant-Murley [19] and Disability Arm
Shoulder and Hand score (DASH) [20] scoring systems
will be performed at the 3 month and 9 month reviews.
The Constant-Murley score [19] is a practitioner com-
pleted objective score on a scale of 100 points divided
into section for pain, activity, range of movement and
strength and is measured for both arms. The Constant-
Murley Score is one of the most used shoulder evalua-
tion tool. This scoring system includes both physical
examination tests and subjective evaluations by the
patients allowing a functional assessment of the
shoulder independently by the specific type of disorder.
The Constant-Murley Score is divided into 4 subscales:
Pain (15 points); Activities of daily living (ADL) (20
points); Range of Motion (ROM) (40 points) and
Strength (25 points). The Pain and the ADL scales are
self-reported by patients: in the first version of the Con-
stant-Murley Score, the pain scale was scored as none
(15 points); mild (10 points); moderate (5 points) and
severe (0 points). In the revised version of 2008, the
pain scale is scored by a VAS. The ADL score is divided
into 4 items: Sleep, 2 points; Work and Recreational
Activities/Sport 4 points each; Positioning the Hand in
the Space, 10 points. ROM is evaluated as the active ele-
vation of the arms on the sagittal and lateral planes and
the internal and external rotation of the shoulders,
10 points each. Finally, strength is evaluated as the
number of pounds of pull that the patient can resist in
abduction to a maximum of 25 points. The total possi-
ble score is 100 points, indicating an asymptomatic and
healthy person, while the worst score is 0 points. The
validity and responsiveness of Constant-Murley Score
were evaluated in successive studies [22]. Evaluating
construct validity, the Constant-Murley Score showed
strong correlation with other scales. Evaluating reliabil-
ity, ICCs varied from 0.84 to 0.87.
The DASH score [20] is a patient completed subjective
score with 30 analogue scale responses producing a score
between 0 and 100 points. The DASH score is a
standardized questionnaire that assesses the symptoms
and functional status in people with different upper
extremity musculoskeletal disorders. The questionnaire
consists of three sections: Symptoms, Sport and Music,
Work. The first section is composed by 30 items and
evaluates symptoms and functional status at the level of
disability. The second and third sections are an optional
module of four items for Sport and Music and four items
for Work. Each item is scored with a five point scale: 1 =
no difficulty; 2 = mild difficulty; 3 = moderate difficulty;
4 = severe difficulty; 5 = unable. The result of each mod-
ule is summed and transformed to obtain the DASH
score ranging, for each section, from 0 (no disability) to
100 (severe disability). Relatively to Internal Consistency
the DASH has shown in multiple tests to have a high
Cronbach’s alpha (0.97); the responsiveness of the ques-
tionnaire (to self-rated or expected change) was compar-
able with or better than that of the joint-specific
measures in the whole group and in each region [23].
An independent physiotherapy practitioner not
involved in patient’s surgical care or rehabilitation pro-
gram will administer both assessment tools. There will a
different examinator in each centre, who will be trained
for the purpose of this study. The Constant score will
be performed in a standardized way, using the same
dynamometer in all the centres.
In the event of a patient developing a non-union at
12 weeks or more, he/she will exit the trial and be
offered surgical management. Data regarding treatment
offered and pursued will be collected.
Adverse Events or Complications
An adverse event or complication will be defined as any
event that necessitated another operative procedure or
additional medical treatment. Non-union will be defined
as the lack of radiographic healing with clinical evidence
of pain and motion at the fracture site at 3 months.
Symptomatic mal-union will be defined as union of the
fracture in a shortened, angulated, or displaced position
with weakness, easy fatigability, pain on overhead activ-
ity, neurologic symptoms, and shoulder asymmetry with
a completed or planned corrective osteotomy.
Complex regional pain syndrome will be diagnosed by
the presence of dysaesthetic pain and hyperaesthesia
extending into the hand of the involved limb, vasomotor
changes, skin atrophy, and diffuse osteopenia [24].
Sample size
Based on a comparison of the percentages of patients
with a non union at 12 weeks following treatment, it is
estimated that 141 patients will be required in each
treatment group to detect at least a reduction in percen-
tages from 15% [6] to 5% non union with 80% power
and a significance level of 5% [25]. A 4% non union rate
has been quoted in the literature [26], however for the
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maximum acceptable clinical failure rate. By randomis-
ing 300 patients (150 per group) the study will be ade-
quately powered with allowance for loss to followup.
Recruitment of 300 subjects will also ensure at least
80% power to detect clinically important effects for sec-
ondary outcomes. For the DASH score this will allow
detection of a 3.3 point difference in mean scores with a
significance level of 5% (assuming a standard deviation
of 10) [20]. For the Constant-Murley score a 5 point dif-
ference in mean scores will be detectable at a 5% signifi-
cance level (assuming a standard deviation of 14.5) [19].
Calculations have assumed approximate Normality of
the scores [25].
It is estimated that 13 patients per month will be
recruited to the study. This would lead to a total period
of recruitment for the trial of 23 months.
Data Analysis
The success of randomisation will be made in a visual
comparison of the baseline characteristics of those ran-
domised to the two groups: centre, age, gender, side of
injury, mechanism of injury, fracture classification [21]
and ASA grade.
The representativeness of the groups randomised to
the trial will be examined by comparing their baseline
characteristics with those who were eligible but refused
to participate.
The primary outcome is the rate of non union in each
group at 3 months. Secondary outcomes are Constant-
Murley and DASH scores at 3 months and 9 months
following injury.
All of the analyses will use the intention-to-treat prin-
ciple. The primary outcome will be compared between
the conservative and operative groups using generalised
linear regression models both unadjusted and adjusted
for centre (the stratification factor), age, fracture classifi-
cation and ASA grade. Estimates of the difference in
proportions and odds ratio with associated 95% confi-
dence intervals will be obtained.
The Constant-Murley and DASH outcomes will be
compared between groups using analysis of covariance.
This will allow for a baseline score as suggested through
measurements recorded for the other normal limb. The
assumptions of this approach will be checked using
summary information and graphs. If assumptions are
not met, appropriate data transform or non parametric
methods will be considered. Multiple regression models
will be used to investigate the intervention effect after
adjustment for centre, age, fracture classification and
ASA grade.
Where outcome data are missing, a check of the char-
acteristics of those with and without the outcome of
interest will be carried out to ensure that missing data
have not biased a comparison based on complete data.
All analyses will be carried out using Stata.
Trial timeline
Following a successful initial application for a British
Society of Elbow and Shoulder Surgery primer grant, a
period of 1 year for trial preparation, obtaining ethics
approval, and Research and Development approval, a
6 month period establishing and piloting of all trial
materials and processes was commenced at the Royal
Free Hospital in December 2007, the official start date
for general recruitment was July 2008. The award of a
BUPA foundation grant allowed the appointment of a
dedicated researcher in 2010 and the subsequently
inclusion on National Institute of Health Research port-
folio of clinical trials has allowed expansion of the trial
sites. Currently there are 4 sites recruiting, and 4 further
sites are planned, 2 of which have approval in place. The
further planned recruitment period is 18 months, and
completion of follow-up 9 months later. Study comple-
tion, which includes submission of the draft trial report
to the funders for publication is scheduled for December
2012. The date of registration of the trial is 07/09/2006.
The date the first patient was recruited is 18/12/2007.
Dissemination of trial findings
We shall disseminate our findings through relevant
local, national and international conferences and peer-
reviewed publications. Reflecting the collaborative basis
of this research, all active contributors will be named
and credited in the main report.
Trial management
The day to day management of the project is the
responsibility of the Trial Management Group:
￿ Clinical co-ordination: Philip Michael Ahrens (Chief
Investigator).
￿ Trial management: Emily Tims (Trial Co-ordinator,
Royal Free Hospital), Suzanne Hodgson, Clinical Trial
Co-ordinator (University College London), replaced by
Temi Giwa (Univerity College London), Clinical Trial
Co-ordinator, August 2010.
￿ Methodological support: Julie Barber (University
College London).
The Trial Steering Committee is at the University Col-
lege London Clinical Trials Unit. Specifically assigned to
the Clavicle trial are a Statistician (Dr Julie Barber), a
trial co-ordinator (Temi Giwa) and a Data Manager (Ms
Kadija Rantell).
Discussion
This article describes version 2.0 (01/09/10) of the pro-
tocol for a multicentre randomised controlled trial of
conservative management versus ORIF for mid-shaft
clavicle fractures in adults. Various adjustments, all
approved by ethics, have been made to the original pro-
tocol approved by ethics. Many changes were
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to feedback, and to overcome practical barriers in trial
recruitment. All changes, which have been fully docu-
mented, are likely to improve the prospects of the trial
successfully meeting its aims.
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